Dermatology firm Galderma has turned to Signature Communications to promote a new cosmetic product to take on market leader Botox.

The Hertfordshire-based healthcare shop beat more established rivals to land the brief, which industry sources claim is worth a significant six-figure sum, for Galderma's cosmetic portfolio, following a competitive pitch. It includes promoting the firm's new botulinum toxin Azzalure.

The product, a competitor to Botox, which is produced by Allergan, was launched into the market last year.

(Read More...)

Thirty to forty years ago, sun awareness campaigns to convey skin damage did not exist. As a result, a large percentage of the UK population aged 50+ now have signs of sun damage and are widely susceptible to non-melanoma skin cancers such as actinic keratosis, basal cell carcinoma and squamous cell carcinoma.

With rates of skin cancer having doubled in the last 15 years, Skcin joined forces with Almirall to launch a new campaign to help people become skin aware, as well as sun smart. The campaign was about reinforcing the ‘safe sun’ message and encouraging those who may already have damage to be ‘skin aware’ – by taking note of changes in its appearance, strange lesions and seeking appropriate advice promptly.

Click here to learn more...

Almirall UK has appointed Signature Healthcare Communications as its UK medical education and PR agency.

The agency has been appointed following a competitive pitch and will work initially on the Solaraze brand, as well as the wider dermatology portfolio later this year.

The agency will kick off implementing a co-ordinated medical education and disease awareness programme for Solaraze.  The campaign, which is being implemented on a nationwide and targeted regional basis, will aim to raise awareness of actinic keratosis; skin lesions caused by sun damage which can be a precursor to skin cancer. (Read More...)

A revolutionary breakthrough drug that treats chronic pain could benefit hundreds of thousands of patients, say doctors.

By Daily Mail Reporter (Read the Article)